Lataa...
Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors
Proteasome inhibitors (PIs) have markedly improved response rates as well as the survival of multiple myeloma (MM) patients over the past decade and have become an important foundation in the treatment of MM patients. Unfortunately, the majority of patients either relapses or becomes refractory to p...
Tallennettuna:
| Julkaisussa: | J Control Release |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6822276/ https://ncbi.nlm.nih.gov/pubmed/31121280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.05.026 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|